An RF engineer explains why packet loss, multipath interference, and battery tradeoffs are scientific validity issues, not IT problems.
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Using RWE To Get To Insights And Action — Faster
Delve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.
-
The Future Of Data Linkage In Clinical Trial Evidence Generation
Explore key questions about the future of AI and data linkage in clinical trial evidence generation.
-
Biosample Tracking: A Consenting Dilemma
Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
RWD/RWE In 2023: Regulatory Policy World Tour
Learn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe.
-
An Expert's View On Choosing And Developing An eCOA Strategy
Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
Early-Stage Biotech's AI Advantage Is A Window That Closes
The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.
-
How AI And ML Can Transform Clinical Trial Conduct
There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
What Happened At ASCO 2024
Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
RECENT NEWSLETTERS
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos